Foghorn Therapeutics (FHTX) Stock: Buy, Sell, or Hold?
FHTX - Foghorn Therapeutics Inc. Common Stock
$2.00
0.01 (0.50%)
▲
5d:
-0.99%
30d:
-55.46%
90d:
-63.24%
HOLD
LOW Confidence
Analysis Updated: Oct 9, 2026 12:00 AM ET
Earnings: Nov 04, 2026
23d
Get Alerted When FHTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FHTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: FHTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: FHTX is currently trading at $2.00, which is considered oversold relative to its 30-day fair value range of $3.06 to $5.13.
Technical Outlook: Technically, FHTX is showing sideways momentum. Immediate support is located at $1.79, while resistance sits at $3.62.
Market Sentiment: FHTX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+200.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FHTX is showing sideways momentum. Immediate support is located at $1.79, while resistance sits at $3.62.
Market Sentiment: FHTX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.00 (+200.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.06 -
$5.13
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 200.0% below Wall St target ($6.00)
- CAUTION: Bottoming setup, but lagging the sector by 61% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.06 -
$5.13
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.79
Resistance Level
$3.62
Current Trend
Sideways
Technical data as of
Oct 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.95
Wall Street Target
$6.00
(+200.0%)
Revenue Growth (YoY)
112.7%
Profit Margin
-175.8%
Share & Embed Analysis
Last updated: October 11, 2026 5:17 PM ET
Data refreshes hourly during market hours. Next update: 6:17 PM
Data refreshes hourly during market hours. Next update: 6:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FHTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
27 analysts |
$859 | 52 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$32 | 63 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 36 SELL |
|
PHVS
Pharvaris BV |
STRONG BUY
14 analysts |
$57 | 69 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 51 HOLD |
